<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Peripheral_blood_smear</id>
	<title>Peripheral blood smear - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Peripheral_blood_smear"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Peripheral_blood_smear&amp;action=history"/>
	<updated>2026-04-18T02:50:56Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Peripheral_blood_smear&amp;diff=386255&amp;oldid=prev</id>
		<title>Danbot: Formatting: removed bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Peripheral_blood_smear&amp;diff=386255&amp;oldid=prev"/>
		<updated>2026-03-19T16:15:12Z</updated>

		<summary type="html">&lt;p&gt;Formatting: removed bold&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:15, 19 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l100&quot;&gt;Line 100:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 100:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Differential Diagnosis==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Differential Diagnosis==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Conditions Diagnosed or Strongly Suggested by PBS===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Conditions Diagnosed or Strongly Suggested by PBS===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Thrombotic microangiopathy (TTP/HUS/DIC):&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Schistocytes + thrombocytopenia&amp;lt;ref name=&amp;quot;zini&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Thrombotic microangiopathy (TTP/HUS/DIC): Schistocytes + thrombocytopenia&amp;lt;ref name=&amp;quot;zini&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Acute leukemia:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Circulating blasts; Auer rods pathognomonic for AML&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Acute leukemia: Circulating blasts; Auer rods pathognomonic for AML&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Malaria/Babesiosis:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Intra-erythrocytic parasites&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Malaria/Babesiosis: Intra-erythrocytic parasites&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Sickle cell disease:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Sickle cells on smear&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Sickle cell disease: Sickle cells on smear&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;DIC:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Schistocytes + thrombocytopenia + abnormal coagulation studies&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*DIC: Schistocytes + thrombocytopenia + abnormal coagulation studies&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Myelofibrosis/Marrow infiltration:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Tear-drop cells + nucleated RBCs + left shift (leukoerythroblastic picture)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Myelofibrosis/Marrow infiltration: Tear-drop cells + nucleated RBCs + left shift (leukoerythroblastic picture)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;CLL:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Absolute lymphocytosis + smudge cells&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*CLL: Absolute lymphocytosis + smudge cells&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Megaloblastic anemia:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Macro-ovalocytes + hypersegmented neutrophils&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Megaloblastic anemia: Macro-ovalocytes + hypersegmented neutrophils&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;AIHA:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;Spherocytes + polychromasia + positive Coombs test&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*AIHA: Spherocytes + polychromasia + positive Coombs test&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Evaluation==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Evaluation==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l136&quot;&gt;Line 136:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 136:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Management is directed by the underlying diagnosis suggested or confirmed by the PBS:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Management is directed by the underlying diagnosis suggested or confirmed by the PBS:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Schistocytes identified + thrombocytopenia:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Schistocytes identified + thrombocytopenia:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Assume TMA until proven otherwise — calculate '''PLASMIC score''' if TTP is suspected&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Assume TMA until proven otherwise — calculate '''PLASMIC score''' if TTP is suspected&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Send ADAMTS13 activity level (results take days; do not delay treatment)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Send ADAMTS13 activity level (results take days; do not delay treatment)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l142&quot;&gt;Line 142:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 142:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**'''Do NOT transfuse platelets''' in suspected TTP (may worsen microvascular thrombosis)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**'''Do NOT transfuse platelets''' in suspected TTP (may worsen microvascular thrombosis)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Evaluate for DIC (PT/INR, PTT, fibrinogen, D-dimer) — abnormal coagulation studies favor DIC over TTP&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Evaluate for DIC (PT/INR, PTT, fibrinogen, D-dimer) — abnormal coagulation studies favor DIC over TTP&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Blasts on smear:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Blasts on smear:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Emergent hematology/oncology consultation&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Emergent hematology/oncology consultation&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Evaluate for [[Tumor Lysis Syndrome|tumor lysis syndrome]] (potassium, phosphorus, uric acid, calcium, LDH, creatinine)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Evaluate for [[Tumor Lysis Syndrome|tumor lysis syndrome]] (potassium, phosphorus, uric acid, calcium, LDH, creatinine)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If WBC &amp;gt; 100,000/μL with blasts → concern for [[Leukostasis|leukostasis]]; may require emergent leukapheresis&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If WBC &amp;gt; 100,000/μL with blasts → concern for [[Leukostasis|leukostasis]]; may require emergent leukapheresis&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**'''Do not delay flow cytometry and bone marrow biopsy'''&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**'''Do not delay flow cytometry and bone marrow biopsy'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Malaria parasites:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Malaria parasites:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Calculate percent parasitemia from thin smear&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Calculate percent parasitemia from thin smear&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&amp;gt; 5% parasitemia or any evidence of severe malaria (altered mentation, renal failure, severe anemia, ARDS) → IV artesunate&amp;lt;ref name=&amp;quot;rosenthal&amp;quot;&amp;gt;Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. ''N Engl J Med''. 2008;358(17):1829-1836. PMID 18434654.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&amp;gt; 5% parasitemia or any evidence of severe malaria (altered mentation, renal failure, severe anemia, ARDS) → IV artesunate&amp;lt;ref name=&amp;quot;rosenthal&amp;quot;&amp;gt;Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. ''N Engl J Med''. 2008;358(17):1829-1836. PMID 18434654.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Infectious disease consultation&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Infectious disease consultation&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Spherocytes + hemolysis labs:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Spherocytes + hemolysis labs:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Send direct Coombs (direct antiglobulin test)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Send direct Coombs (direct antiglobulin test)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If positive → autoimmune hemolytic anemia; consider steroids&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If positive → autoimmune hemolytic anemia; consider steroids&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If negative → consider hereditary spherocytosis, delayed transfusion reaction&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**If negative → consider hereditary spherocytosis, delayed transfusion reaction&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Leukoerythroblastic picture&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(tear-drop cells + nucleated RBCs + immature granulocytes):&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Leukoerythroblastic picture (tear-drop cells + nucleated RBCs + immature granulocytes):&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Suggests marrow infiltration (myelofibrosis, metastatic disease, granulomatous disease)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Suggests marrow infiltration (myelofibrosis, metastatic disease, granulomatous disease)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Hematology consultation for bone marrow biopsy&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Hematology consultation for bone marrow biopsy&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Disposition==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Disposition==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Admit:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Admit:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Schistocytes with thrombocytopenia (suspected TMA) — often to ICU; emergent plasma exchange for TTP&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Schistocytes with thrombocytopenia (suspected TMA) — often to ICU; emergent plasma exchange for TTP&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Blasts on peripheral smear (suspected acute leukemia)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Blasts on peripheral smear (suspected acute leukemia)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l166&quot;&gt;Line 166:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 166:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Symptomatic anemia requiring transfusion with unclear etiology&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Symptomatic anemia requiring transfusion with unclear etiology&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Pancytopenia with fever&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Pancytopenia with fever&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Discharge with urgent follow-up may be appropriate for:&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Discharge with urgent follow-up may be appropriate for:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Mild morphologic abnormalities (e.g. target cells, mild poikilocytosis) with stable CBC and known chronic condition&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Mild morphologic abnormalities (e.g. target cells, mild poikilocytosis) with stable CBC and known chronic condition&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Confirmed pseudothrombocytopenia with normal citrate platelet count&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Confirmed pseudothrombocytopenia with normal citrate platelet count&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Peripheral_blood_smear&amp;diff=386041&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;==Background== *The peripheral blood smear (PBS), also called a blood film, involves microscopic examination of a stained blood sample to evaluate cell morphology across all three cell lines (red blood cells, white blood cells, and platelets)&lt;ref name=&quot;lynch&quot;&gt;Lynch EC. Peripheral Blood Smear. In: Walker HK, Hall WD, Hurst JW, eds. ''Clinical Methods: The History, Physical, and Laboratory Examinations''. 3rd ed. Boston: Butterworths; 1990. Chapter 155. PMID 21250105.&lt;/ref...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Peripheral_blood_smear&amp;diff=386041&amp;oldid=prev"/>
		<updated>2026-03-12T17:19:34Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Background== *The peripheral blood smear (PBS), also called a blood film, involves microscopic examination of a stained blood sample to evaluate cell morphology across all three cell lines (red blood cells, white blood cells, and platelets)&amp;lt;ref name=&amp;quot;lynch&amp;quot;&amp;gt;Lynch EC. Peripheral Blood Smear. In: Walker HK, Hall WD, Hurst JW, eds. &amp;#039;&amp;#039;Clinical Methods: The History, Physical, and Laboratory Examinations&amp;#039;&amp;#039;. 3rd ed. Boston: Butterworths; 1990. Chapter 155. PMID 21250105.&amp;lt;/ref...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Background==&lt;br /&gt;
*The peripheral blood smear (PBS), also called a blood film, involves microscopic examination of a stained blood sample to evaluate cell morphology across all three cell lines (red blood cells, white blood cells, and platelets)&amp;lt;ref name=&amp;quot;lynch&amp;quot;&amp;gt;Lynch EC. Peripheral Blood Smear. In: Walker HK, Hall WD, Hurst JW, eds. ''Clinical Methods: The History, Physical, and Laboratory Examinations''. 3rd ed. Boston: Butterworths; 1990. Chapter 155. PMID 21250105.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Follows the [[CBC|complete blood count (CBC)]] as the second most performed test in the hematology laboratory&amp;lt;ref name=&amp;quot;bain&amp;quot;&amp;gt;Bain BJ. Diagnosis from the blood smear. ''N Engl J Med''. 2005;353(5):498-507. PMID 16079373.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Provides morphologic information that automated hematology analyzers cannot — including cell shape abnormalities, inclusions, parasites, and immature/atypical cells&amp;lt;ref name=&amp;quot;adewoyin&amp;quot;&amp;gt;Adewoyin AS, Nwogoh B. Peripheral blood film — a review. ''Ann Ib Postgrad Med''. 2014;12(2):71-79. PMID 25960697.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Stained using Wright or Wright-Giemsa stain; examined under light microscopy at 100× (oil immersion) for morphologic detail&lt;br /&gt;
*Collected in an EDTA (purple/lavender top) tube; smear should ideally be prepared within 2 hours of collection to minimize artifact&lt;br /&gt;
*Approximately 10–25% of CBC samples trigger a manual smear review based on abnormal automated flags or institutional criteria&amp;lt;ref name=&amp;quot;craig&amp;quot;&amp;gt;Craig FE, Roth CG. The utility of peripheral blood smear review for identifying specimens for flow cytometric immunophenotyping. ''Int J Lab Hematol''. 2017;39(4):363-368. PMID 28444824.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
The PBS is a diagnostic tool, not a clinical condition. It is ordered when the clinical picture or CBC abnormalities suggest a diagnosis requiring morphologic confirmation. Key morphologic findings and their clinical associations are outlined below.&lt;br /&gt;
&lt;br /&gt;
===Red Blood Cell Morphology===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Finding !! Description !! Clinical Association&lt;br /&gt;
|-&lt;br /&gt;
| '''Schistocytes''' || Fragmented RBCs (helmet cells, triangles, crescents) || [[TTP]]/[[HUS]], [[DIC]], [[HELLP Syndrome|HELLP]], mechanical heart valves, malignant hypertension; ≥ 1% is suggestive of thrombotic microangiopathy (TMA)&amp;lt;ref name=&amp;quot;zini&amp;quot;&amp;gt;Zini G, d'Onofrio G, Briggs C, et al. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. ''Int J Lab Hematol''. 2012;34(2):107-116. PMID 22081912.&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| '''Spherocytes''' || Small, round RBCs lacking central pallor || [[Hereditary Spherocytosis|Hereditary spherocytosis]], autoimmune hemolytic anemia (warm AIHA), transfusion reactions, burns&lt;br /&gt;
|-&lt;br /&gt;
| '''Sickle cells (drepanocytes)''' || Crescent/sickle-shaped RBCs || [[Sickle Cell Disease|Sickle cell disease]]&lt;br /&gt;
|-&lt;br /&gt;
| '''Target cells (codocytes)''' || Bull's-eye appearance with central and peripheral hemoglobin || Thalassemia, hemoglobin C disease, liver disease, iron deficiency, post-splenectomy&lt;br /&gt;
|-&lt;br /&gt;
| '''Tear-drop cells (dacrocytes)''' || Drop-shaped RBCs || Myelofibrosis, bone marrow infiltration (myelophthisis), thalassemia major, megaloblastic anemia&lt;br /&gt;
|-&lt;br /&gt;
| '''Burr cells (echinocytes)''' || Evenly spaced short spicules with preserved central pallor || Uremia/renal failure, artifact (drying, EDTA); may be seen in liver disease&lt;br /&gt;
|-&lt;br /&gt;
| '''Acanthocytes (spur cells)''' || Irregularly spaced thorny projections || Severe liver disease (spur cell anemia), abetalipoproteinemia, post-splenectomy&lt;br /&gt;
|-&lt;br /&gt;
| '''Rouleaux formation''' || RBCs stacked like coins || Multiple myeloma, Waldenström macroglobulinemia, chronic inflammation, elevated ESR&lt;br /&gt;
|-&lt;br /&gt;
| '''Howell-Jolly bodies''' || Nuclear remnants (dark inclusions) within RBCs || Post-splenectomy, functional asplenia (e.g. sickle cell disease), megaloblastic anemia&lt;br /&gt;
|-&lt;br /&gt;
| '''Basophilic stippling''' || Aggregated ribosomal RNA appearing as blue dots || [[Lead Poisoning|Lead poisoning]], thalassemia, sideroblastic anemia, myelodysplastic syndrome&lt;br /&gt;
|-&lt;br /&gt;
| '''Heinz bodies''' || Denatured hemoglobin inclusions (require supravital stain) || G6PD deficiency (during hemolytic crisis), unstable hemoglobin variants, oxidant drug exposure&lt;br /&gt;
|-&lt;br /&gt;
| '''Polychromasia''' || Bluish-gray tint to RBCs (reticulocytes) || Active bone marrow response to anemia (hemolysis, acute blood loss)&lt;br /&gt;
|-&lt;br /&gt;
| '''Hypersegmented neutrophils''' || Neutrophils with ≥ 5 lobes (or &amp;gt; 5% with 5 lobes) || Vitamin B12 or folate deficiency (megaloblastic anemia)&lt;br /&gt;
|-&lt;br /&gt;
| '''Nucleated RBCs''' || RBCs with retained nuclei (normoblasts) || Severe anemia, hemolysis, myelophthisic processes (bone marrow infiltration), extramedullary hematopoiesis, neonates (normal finding)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===White Blood Cell Morphology===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Finding !! Description !! Clinical Association&lt;br /&gt;
|-&lt;br /&gt;
| '''Blasts''' || Large immature cells with high nuclear-to-cytoplasmic ratio, fine chromatin, prominent nucleoli || Acute leukemia (AML, ALL) — '''hematologic emergency''' requiring immediate consultation&amp;lt;ref name=&amp;quot;bain&amp;quot;/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| '''Left shift''' || Increased immature granulocytes (bands, metamyelocytes, myelocytes) || Severe bacterial infection, sepsis, physiologic stress, myeloproliferative disorders&lt;br /&gt;
|-&lt;br /&gt;
| '''Toxic granulation''' || Prominent dark granules in neutrophil cytoplasm || Severe infection/sepsis, inflammation&lt;br /&gt;
|-&lt;br /&gt;
| '''Döhle bodies''' || Light blue cytoplasmic inclusions in neutrophils || Severe infection, burns, May-Hegglin anomaly&lt;br /&gt;
|-&lt;br /&gt;
| '''Toxic vacuolization''' || Cytoplasmic vacuoles in neutrophils || Severe sepsis/bacteremia (associated with high specificity for bacteremia)&lt;br /&gt;
|-&lt;br /&gt;
| '''Auer rods''' || Pink rod-shaped crystalline inclusions in blast cytoplasm || '''Pathognomonic for AML''' (especially APL/M3); '''hematologic emergency'''&lt;br /&gt;
|-&lt;br /&gt;
| '''Atypical lymphocytes''' || Large lymphocytes with abundant pale blue cytoplasm and scalloped borders (&amp;quot;Downey cells&amp;quot;) || Infectious mononucleosis (EBV), CMV, other viral infections, drug reactions&lt;br /&gt;
|-&lt;br /&gt;
| '''Smudge cells''' || Fragile lymphocytes that rupture during smear preparation || [[Chronic Lymphocytic Leukemia|CLL]] (when numerous)&lt;br /&gt;
|-&lt;br /&gt;
| '''Pelger-Huët anomaly''' || Bilobed neutrophils || Inherited (benign); acquired (pseudo-Pelger-Huët) in myelodysplastic syndrome&lt;br /&gt;
|-&lt;br /&gt;
| '''Hypersegmented neutrophils''' || ≥ 5 nuclear lobes || Megaloblastic anemia (B12/folate deficiency)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Platelet Morphology===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Finding !! Description !! Clinical Association&lt;br /&gt;
|-&lt;br /&gt;
| '''Platelet clumps''' || Aggregated platelets on smear || Pseudothrombocytopenia (EDTA-dependent clumping) — falsely low automated platelet count; re-draw in citrate tube to confirm&amp;lt;ref name=&amp;quot;bain&amp;quot;/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| '''Giant platelets''' || Platelets approaching or exceeding RBC size || Bernard-Soulier syndrome, May-Hegglin anomaly, [[ITP]] (young active platelets), myeloproliferative disorders&lt;br /&gt;
|-&lt;br /&gt;
| '''Decreased platelets on smear''' || &amp;lt; 1 platelet per oil-immersion field || True thrombocytopenia (each platelet per OIF ≈ 10,000–15,000/μL)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Infectious Organisms===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Finding !! Clinical Association&lt;br /&gt;
|-&lt;br /&gt;
| '''Malaria parasites''' (intra-erythrocytic rings, gametocytes, schizonts) || [[Malaria]] — thick smear for detection, thin smear for speciation; gold standard diagnostic test&amp;lt;ref name=&amp;quot;adewoyin&amp;quot;/&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| '''Babesia''' (intra-erythrocytic ring forms, Maltese cross/tetrad) || [[Babesiosis]] — may resemble ''Plasmodium falciparum''&lt;br /&gt;
|-&lt;br /&gt;
| '''Anaplasma/Ehrlichia morulae''' (intracytoplasmic inclusions in granulocytes or monocytes) || [[Anaplasmosis]]/[[Ehrlichiosis]]&lt;br /&gt;
|-&lt;br /&gt;
| '''Borrelia spirochetes''' (rare) || [[Relapsing Fever]]&lt;br /&gt;
|-&lt;br /&gt;
| '''Trypanosomes''' || [[Trypanosomiasis]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
===Conditions Diagnosed or Strongly Suggested by PBS===&lt;br /&gt;
*'''Thrombotic microangiopathy (TTP/HUS/DIC):''' Schistocytes + thrombocytopenia&amp;lt;ref name=&amp;quot;zini&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Acute leukemia:''' Circulating blasts; Auer rods pathognomonic for AML&lt;br /&gt;
*'''Malaria/Babesiosis:''' Intra-erythrocytic parasites&lt;br /&gt;
*'''Sickle cell disease:''' Sickle cells on smear&lt;br /&gt;
*'''DIC:''' Schistocytes + thrombocytopenia + abnormal coagulation studies&lt;br /&gt;
*'''Myelofibrosis/Marrow infiltration:''' Tear-drop cells + nucleated RBCs + left shift (leukoerythroblastic picture)&lt;br /&gt;
*'''CLL:''' Absolute lymphocytosis + smudge cells&lt;br /&gt;
*'''Megaloblastic anemia:''' Macro-ovalocytes + hypersegmented neutrophils&lt;br /&gt;
*'''AIHA:''' Spherocytes + polychromasia + positive Coombs test&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===ED Indications for Ordering a Peripheral Blood Smear===&lt;br /&gt;
*Unexplained anemia, especially when etiology is unclear from CBC indices alone&lt;br /&gt;
*Thrombocytopenia — to rule out pseudothrombocytopenia (platelet clumps) and evaluate for schistocytes (TMA)&amp;lt;ref name=&amp;quot;zini&amp;quot;/&amp;gt;&lt;br /&gt;
*Suspected [[TTP]], [[HUS]], [[DIC]], or [[HELLP Syndrome|HELLP]] — '''schistocyte identification is essential for TMA diagnosis and should not be delayed'''&lt;br /&gt;
*Suspected acute [[Leukemia|leukemia]] — blasts on smear → emergent hematology consultation&lt;br /&gt;
*Suspected [[Malaria|malaria]] or [[Babesiosis|babesiosis]] — thick and thin smear remain the gold standard&amp;lt;ref name=&amp;quot;adewoyin&amp;quot;/&amp;gt;&lt;br /&gt;
*Pancytopenia or leukoerythroblastic picture&lt;br /&gt;
*Unexplained leukocytosis with concern for malignancy&lt;br /&gt;
*Clinical suspicion of [[Sickle Cell Disease|sickle cell crisis]] in an undiagnosed patient&lt;br /&gt;
*Fever in a returning traveler&lt;br /&gt;
&lt;br /&gt;
===How to Order===&lt;br /&gt;
*Order &amp;quot;peripheral blood smear with pathologist review&amp;quot; or &amp;quot;manual differential with smear&amp;quot; — terminology varies by institution&lt;br /&gt;
*Specify clinical question (e.g. &amp;quot;evaluate for schistocytes&amp;quot; or &amp;quot;rule out blasts&amp;quot;) to guide the reviewing pathologist or technologist&lt;br /&gt;
*If malaria is suspected, order &amp;quot;thick and thin blood smears for malaria parasites&amp;quot; — standard Wright-stained smear may not be optimized for parasite detection&lt;br /&gt;
&lt;br /&gt;
===Interpreting Results===&lt;br /&gt;
*Smear results should always be interpreted alongside the CBC, clinical context, and other labs&amp;lt;ref name=&amp;quot;adewoyin&amp;quot;/&amp;gt;&lt;br /&gt;
*A single negative malaria smear does not exclude infection; repeat every 12–24 hours for 3 sets if clinical suspicion is high&lt;br /&gt;
*Absence of schistocytes does not definitively exclude TMA; a threshold of ≥ 1% schistocytes supports the diagnosis, but clinical judgment should prevail&amp;lt;ref name=&amp;quot;zini&amp;quot;/&amp;gt;&lt;br /&gt;
*Smear artifacts (echinocyte formation from alkaline stain, stomatocytes from acidic stain, crenated cells from drying) should be recognized and not misinterpreted&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
Management is directed by the underlying diagnosis suggested or confirmed by the PBS:&lt;br /&gt;
&lt;br /&gt;
*'''Schistocytes identified + thrombocytopenia:'''&lt;br /&gt;
**Assume TMA until proven otherwise — calculate '''PLASMIC score''' if TTP is suspected&lt;br /&gt;
**Send ADAMTS13 activity level (results take days; do not delay treatment)&lt;br /&gt;
**Emergent hematology consultation for [[TTP]] (plasma exchange is lifesaving and should not be delayed)&amp;lt;ref name=&amp;quot;scully&amp;quot;&amp;gt;Scully M, Cataland S, Coppo P, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. ''J Thromb Haemost''. 2017;15(2):312-322. PMID 27868334.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**'''Do NOT transfuse platelets''' in suspected TTP (may worsen microvascular thrombosis)&lt;br /&gt;
**Evaluate for DIC (PT/INR, PTT, fibrinogen, D-dimer) — abnormal coagulation studies favor DIC over TTP&lt;br /&gt;
*'''Blasts on smear:'''&lt;br /&gt;
**Emergent hematology/oncology consultation&lt;br /&gt;
**Evaluate for [[Tumor Lysis Syndrome|tumor lysis syndrome]] (potassium, phosphorus, uric acid, calcium, LDH, creatinine)&lt;br /&gt;
**If WBC &amp;gt; 100,000/μL with blasts → concern for [[Leukostasis|leukostasis]]; may require emergent leukapheresis&lt;br /&gt;
**'''Do not delay flow cytometry and bone marrow biopsy'''&lt;br /&gt;
*'''Malaria parasites:'''&lt;br /&gt;
**Calculate percent parasitemia from thin smear&lt;br /&gt;
**&amp;gt; 5% parasitemia or any evidence of severe malaria (altered mentation, renal failure, severe anemia, ARDS) → IV artesunate&amp;lt;ref name=&amp;quot;rosenthal&amp;quot;&amp;gt;Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. ''N Engl J Med''. 2008;358(17):1829-1836. PMID 18434654.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Infectious disease consultation&lt;br /&gt;
*'''Spherocytes + hemolysis labs:'''&lt;br /&gt;
**Send direct Coombs (direct antiglobulin test)&lt;br /&gt;
**If positive → autoimmune hemolytic anemia; consider steroids&lt;br /&gt;
**If negative → consider hereditary spherocytosis, delayed transfusion reaction&lt;br /&gt;
*'''Leukoerythroblastic picture''' (tear-drop cells + nucleated RBCs + immature granulocytes):&lt;br /&gt;
**Suggests marrow infiltration (myelofibrosis, metastatic disease, granulomatous disease)&lt;br /&gt;
**Hematology consultation for bone marrow biopsy&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''Admit:'''&lt;br /&gt;
**Schistocytes with thrombocytopenia (suspected TMA) — often to ICU; emergent plasma exchange for TTP&lt;br /&gt;
**Blasts on peripheral smear (suspected acute leukemia)&lt;br /&gt;
**Severe parasitemia (malaria &amp;gt; 5% or any signs of severe malaria)&lt;br /&gt;
**Symptomatic anemia requiring transfusion with unclear etiology&lt;br /&gt;
**Pancytopenia with fever&lt;br /&gt;
*'''Discharge with urgent follow-up may be appropriate for:'''&lt;br /&gt;
**Mild morphologic abnormalities (e.g. target cells, mild poikilocytosis) with stable CBC and known chronic condition&lt;br /&gt;
**Confirmed pseudothrombocytopenia with normal citrate platelet count&lt;br /&gt;
**Stable atypical lymphocytosis consistent with viral syndrome&lt;br /&gt;
*Communicate critical smear findings (blasts, schistocytes, parasites) directly with the consulting service — do not rely solely on electronic result notification&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[CBC]]&lt;br /&gt;
*[[Anemia]]&lt;br /&gt;
*[[TTP]]&lt;br /&gt;
*[[Hemolytic Uremic Syndrome]]&lt;br /&gt;
*[[DIC]]&lt;br /&gt;
*[[Leukemia]]&lt;br /&gt;
*[[Neutropenic fever]]&lt;br /&gt;
*[[Malaria]]&lt;br /&gt;
*[[Babesiosis]]&lt;br /&gt;
*[[Sickle Cell Disease]]&lt;br /&gt;
*[[HELLP Syndrome]]&lt;br /&gt;
*[[Thrombocytopenia]]&lt;br /&gt;
*[[Pancytopenia]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK263/ Peripheral Blood Smear - Clinical Methods (NCBI Bookshelf)]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC4415389/ Peripheral Blood Film — A Review (Ann Ib Postgrad Med 2014)]&lt;br /&gt;
*[https://pubmed.ncbi.nlm.nih.gov/22081912/ ICSH recommendations for schistocyte identification and quantitation (Int J Lab Hematol 2012)]&lt;br /&gt;
*[https://pubmed.ncbi.nlm.nih.gov/16079373/ Diagnosis from the blood smear (N Engl J Med 2005)]&lt;br /&gt;
*[https://pubmed.ncbi.nlm.nih.gov/28444824/ Utility of PBS review for identifying specimens for flow cytometry (Int J Lab Hematol 2017)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Labs]]&lt;br /&gt;
[[Category:Heme/Onc]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>